Navigation Links
Action video games sharpen vision 20 percent

Video games that contain high levels of action, such as Unreal Tournament, can actually improve your vision.

Researchers at the University of Rochester have shown that people who played action video games for a few hours a day over the course of a month improved by about 20 percent in their ability to identify letters presented in clutter—a visual acuity test similar to ones used in regular ophthalmology clinics.

In essence, playing video game improves your bottom line on a standard eye chart.

"Action video game play changes the way our brains process visual information," says Daphne Bavelier, professor of brain and cognitive sciences at the University of Rochester. "After just 30 hours, players showed a substantial increase in the spatial resolution of their vision, meaning they could see figures like those on an eye chart more clearly, even when other symbols crowded in."

Bavelier and graduate student Shawn Green tested college students who had played few, if any, video games in the last year. "That alone was pretty tough," says Green. "Nearly everybody on a campus plays video games."

At the outset, the students were given a crowding test, which measured how well they could discern the orientation of a "T" within a crowd of other distracting symbols—a sort of electronic eye chart. Students were then divided into two groups. The experimental group played Unreal Tournament, a first-person shoot-'em-up action game, for roughly an hour a day. The control group played Tetris, a game equally demanding in terms of motor control, but visually less complex.

After about a month of near-daily gaming, the Tetris players showed no improvement on the test, but the Unreal Tournament players could tell which way the "T" was pointing much more easily than they had just a month earlier.

"When people play action games, they're changing the brain's pathway responsible for visual processing," says Bavelier. "T
'"/>

Source:University of Rochester


Page: 1 2

Related biology news :

1. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
2. Creeping crinoids! Sea lilies crawl to escape predators, new video shows
3. APS lecturer shows rare video of teacher-student immune cell interactions in live animal
4. A reason why video games are hard to give up
5. Teenager moves video icons just by imagination
6. Surgeons with video game skill appear to perform better in simulated surgery skills course
7. Computer-based games enhance mental function in patients with Alzheimers
8. New light microscope sharpens scientists focus
9. Needling Chromosomes Reveals Cell Division Secret
10. Key mechanism in genetic inheritance during cell division identified
11. Migratory songbirds have a specialized night-vision brain area

Post Your Comments:
(Date:11/20/2009)...Chronic obstructive pulmonary disease (COPD), a re...itis or emphysema, is the fourth leading cause of ...D and while researchers have yet to find any real ...ch Institute at The University of Western Ontario ...ques to gain new insight into the disease. , ...
(Date:11/19/2009)...It,s a naturally occurring brain chemical with an ...mouth, it can be abused or used as a date-rape dru...s have determined new routes by which 4-HB is meta...formation," said K. Michael Gibson, professor and ...ical University and a member of the research team....
(Date:11/19/2009)...MADISON This week, scientists are revealing the g...ree cereal crops. Corn, or maize, has one of the m...niversity of Wisconsin-Madison genomicist David Sc...e article in the journal Science . , "The maize...and dead-ends that have troubled would-be sequence...
Breaking Biology News(10 mins):Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3Public Health Faith Leaders Call on DC Council to Renew Funding for Successful Tobacco Prevention Programs 57025 1Public Health Faith Leaders Call on DC Council to Renew Funding for Successful Tobacco Prevention Programs 57025 2Public Health Faith Leaders Call on DC Council to Renew Funding for Successful Tobacco Prevention Programs 57025 3Public Health Faith Leaders Call on DC Council to Renew Funding for Successful Tobacco Prevention Programs 57025 4Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 1Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 2Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 3National Certification for Medical Interpreters Public Call for Final Written Pilot Exam 57018 1National Certification for Medical Interpreters Public Call for Final Written Pilot Exam 57018 2
...d a novel method for attaching small molecules, su...re used to capture large biomolecules. By varying...s, researchers can make the technique applicable t...chemical warfare agents, and environmental polluta...ntify synthetic biomolecules that recognize neurot...
...ity of Pennsylvania and Johns Hopkins University h...ommonly activated proteins in cancer is so dangero... Myc protein can stop the production of at least 1...p control which genes are turned on and off., Fur...ressed miRNAs ,into Myc-containing cancer cells su...
...th the designation of Threatened by the Committee ...SEWIC). COSEWIC is the scientific body that advise...at risk. , Since 1967, the number of chimney swi...y swifts are sooty-coloured, swallow-like birds th...rick-lined chimneys. From late April to early Octo...
Other Biology News:Biocapture surfaces produced for study of brain chemistry 2University of Pennsylvania researchers zero in on the tiniest members in the war on cancer 2
(Date:11/20/2009)...OLM, November 20 Karolinska Develo...ent Fund (EIF) has entered into a,co-investment ag...ill be,managed by Karolinska Development and used ...e pharmaceutical and medical technology companies....nvestment fund. The agreement,represents EIF,s lar...
(Date:11/19/2009).... 19 Danish Prince Joachim inaugur...l plant in Kalundborg, Denmark, on Wednesday, Nove...and largest 2nd generation ethanol demonstration b...sed in the plant,s innovative process for converti... was the first to market with commercial enzymes f...
(Date:11/19/2009)... Nov. 19 Spherix Incorpo...ogy for diabetes therapy, and a provider of techni...pplement, biotechnology and pharmaceutical compani...l Meeting of Shareholders. ,, At the meeting, s... ) elected the following members to the Board of D...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies Form Interna...ate Best Practices in Risk Reduction ,Five Membe... Synthesis Capacity , (PR...s leading gene synthesis companies today announced... protocol to promote biosecurity in the gene synth...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...icals, Inc.,a privately held biopharmaceutical com...ounced new data on its lead product, varespladib (...ual Conference in New Orleans,Louisiana. Anthera h...r the,treatment of coronary heart disease. At the ...ased new data from the Phase II PLASMA-2 study, wh...
...cut,s highest honor for technological achievement,...to Yale Professor Tso-Ping (T.P.) Ma for his pio...ut Medal of Technology is awarded by the Board of ...t Academy of Science and Engineering . It is given...Science and is designed to laud individuals "for s...
...rowth of 12.9 percent,- Full year revenue growth o... and improving profitability reflects success of s...ual financial guidance for fiscal year 2009, BATE...E: HRC ), announced unaudited financial results f...008 -- the second quarter of operations,following ...
Other Biology Technology:Anthera's Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease 2Yale professor T.P. Ma awarded the Connecticut Medal of Technology 2Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 2Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 3Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 4Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 5Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 6Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 7Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 8Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 9Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 10Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 11Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 12Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 13Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 14Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 15Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 16Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 17Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 18Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 19
Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-NF-kB p65, phospho (Ser345) Antibody, Unconjugated from Spring Bioscience
Anti-NSP-C (Neuroendocrine-Specific-Protein) Monoclonal Antibody, Unconjugated, Clone RNL-4 from CHEMICON
Rabbit Anti-Human ADAMTS-4, disintegrin-like domain Antibody, Unconjugated from CHEMICON
Biology Products: